POTENTIAL GOLDEN CROSS

An extrapolation of MEDIPHARM LABS' 50-day and 200-day moving average lines suggests a GOLDEN CROSS should take place early next year.

According to The Globe and Mail, the target price for LABS is $0.10:

https://www.theglobeandmail.com/investing/markets/stocks/LABS-T/research/

This represents a 20% upside potential.

GLTA!